Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay Probe, DNA, 96
The Agilent SureSelect Tumor Map Assay Probe, DNA, 96 (part number 5191-6994) is designed for use with the SureSelect platform to enable comprehensive tumor profiling. This assay provides high-quality DNA probes for targeted enrichment and sequencing of tumor samples, supporting the identification of genetic alterations relevant to cancer research. The kit is optimized for high-throughput workflows and is compatible with next-generation sequencing (NGS) technologies, facilitating accurate and efficient analysis of tumor DNA. The 96-reaction format supports scalability for larger studies and clinical research applications.